Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
Health & Biotech
Pharmacists to begin recommending Respiri’s wheezo asthma management device
Health & Biotech
Creso Pharma brings marketing and sales of CannaQIX cannabis lozenge in-house
Health & Biotech
Cann Group gets hit by cyber attack, says it’s given a fraudster $3.6m
Health & Biotech
‘Pure biotech’ play Avecho is making a ‘terrifying’ move. Will it pay off?
Health & Biotech
Incannex says it’s received results that its cannabinoid drug cocktail may work as an asthma treatment
Health & Biotech
MGC Pharma is to become the first medicinal cannabis company to list on the London Stock Exchange
Health & Biotech
Check Up: A rough fortnight for healthcare as most lose ground
Health & Biotech
Weed Week: US Democrats make it official — federal cannabis reform is on the agenda
Health & Biotech
Botanix soars after pot-up-nose study success
Health & Biotech
Apiam pounces on a generational market opportunity amid booming growth in regional Australia
Health & Biotech
Creso Pharma’s Canadian cannabis subsidiary picking up speed with more purchase orders
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.